There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with ...

PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...

Drug developers are finding new ways to fight an unforgiving disease, including with mRNA technology.

Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even ...

Pancreatic cancer is one of the deadliest diagnoses. American Cancer Society data shows only about 13% of patients live five ...

As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

Pancreatic cancer’s deadliest trait may be its ability to stay invisible — and researchers in Rochester say they are ...

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

Stage 2 pancreatic cancer includes stages 2A and 2B. Stage 2A is when the cancer tumor has grown to over 4 centimeters (cm). Stage 2B is when it has spread from the pancreas to up to three nearby ...

With Pancreatic Cancer Research at an Extraordinary Turning Point, PanCAN Unveils Ambitious 5-Year, $250 Million Campaign to ...